These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2221859)

  • 1. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells.
    Raoult D; Drancourt M; Vestris G
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1512-4. PubMed ID: 2221859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.
    Maurin M; Benoliel AM; Bongrand P; Raoult D
    J Infect Dis; 1992 Nov; 166(5):1097-102. PubMed ID: 1402021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.
    Yeaman MR; Roman MJ; Baca OG
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1052-7. PubMed ID: 2782856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.
    Yeaman MR; Mitscher LA; Baca OG
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1079-84. PubMed ID: 3662472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media.
    Smith CB; Evavold C; Kersh GJ
    Sci Rep; 2019 Dec; 9(1):18132. PubMed ID: 31792307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii.
    Yeaman MR; Baca OG
    Ann N Y Acad Sci; 1990; 590():297-305. PubMed ID: 2378461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
    Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D
    Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.
    Raoult D; Yeaman MR; Baca OG
    Antimicrob Agents Chemother; 1989 May; 33(5):621-3. PubMed ID: 2751278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.
    Rolain JM; Boulos A; Mallet MN; Raoult D
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2673-6. PubMed ID: 15980335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
    Spyridaki I; Psaroulaki A; Vranakis I; Tselentis Y; Gikas A
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2690-2. PubMed ID: 19332671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.
    Yeaman MR; Baca OG
    Antimicrob Agents Chemother; 1991 May; 35(5):948-54. PubMed ID: 1854176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
    Gikas A; Spyridaki I; Psaroulaki A; Kofterithis D; Tselentis Y
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2747-8. PubMed ID: 9756789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis revealed the survival strategy of Coxiella burnetii to doxycycline exposure.
    Zuñiga-Navarrete F; Flores-Ramirez G; Danchenko M; Benada O; Skriba A; Skultety L
    J Proteomics; 2019 Sep; 208():103479. PubMed ID: 31394312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline.
    Rolain JM; Lambert F; Raoult D
    Ann N Y Acad Sci; 2005 Dec; 1063():252-6. PubMed ID: 16481522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of axenic media to determine antibiotic efficacy against coxiella burnetii.
    Clay KA; Hartley MG; Russell P; Norville IH
    Int J Antimicrob Agents; 2018 May; 51(5):806-808. PubMed ID: 28802854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.
    Peyrusson F; Whelan AO; Hartley MG; Norville IH; Harding SV; Van Bambeke F
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0106121. PubMed ID: 34543094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii.
    Hackstadt T; Williams JC
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3240-4. PubMed ID: 6942430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using
    Clay KA; Hartley MG; Armstrong S; Bewley KR; Godwin K; Rayner E; Vipond J; Bailey M; Atkins TP; Norville IH
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0067321. PubMed ID: 34370577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of intracellular Coxiella burnetii to antimicrobial peptides in mouse fibroblast cells.
    Unsworth NB; Dawson RM; Wade JD; Liu CQ
    Protein Pept Lett; 2014; 21(2):115-23. PubMed ID: 24364858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.